![James Garner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Garner
President at
Hummingbird Bioscience Pte Ltd.
Net worth: 11 088 $ as of 2026-08-30
Profile
Dr. James S.
Garner is a President at Hummingbird Bioscience Pte Ltd. and a Member at Australian Institute of Co. Directors.
Dr. Garner was previously employed as a Chief Executive Officer, MD & Director by Percheron Therapeutics Ltd., a Chief Executive Officer, MD & Executive Director by Kazia Therapeutics Ltd., a Vice President-Research & Development by Takeda Pharmaceuticals Australia Pty Ltd., and a Vice President-Clinical & Medical Affairs by Progen Pharmaceuticals Ltd. He received his undergraduate degree from the University College London, a graduate degree from The University of Queensland and an MBA from The University of Queensland.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-12-23 | 3,080,001 ( 0.2% ) | 11 088 $ | 2026-08-30 |
James Garner active positions
| Companies | Position | Start |
|---|---|---|
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
Hummingbird Bioscience Pte Ltd.
 Hummingbird Bioscience Pte Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | President | 2026-09-14 |
Former positions of James Garner
| Companies | Position | End |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Chief Executive Officer | 2026-08-30 |
| KAZIA THERAPEUTICS LIMITED | Chief Executive Officer | 2023-04-30 |
Takeda Pharmaceuticals Australia Pty Ltd.
 Takeda Pharmaceuticals Australia Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research, development and manufactures medicines | Chief Tech/Sci/R&D Officer | 2012-12-31 |
| TBG DIAGNOSTICS LIMITED | Chief Tech/Sci/R&D Officer | 2008-11-11 |
Training of James Garner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
81
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Kazia Therapeutics Ltd.
 Kazia Therapeutics Ltd. BiotechnologyHealth Technology Engages in the business of pharmaceutical research and development | Health Technology |
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
TBG Diagnostics Ltd.
 TBG Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule pharmaceuticals for the treatment of cancer | Health Technology |
The University of Queensland
 The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Takeda Pharmaceuticals Australia Pty Ltd.
Takeda Pharmaceuticals Australia Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research, development and manufactures medicines | Commercial Services |
Hummingbird Bioscience Pte Ltd.
Hummingbird Bioscience Pte Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
- Stock Market
- Insiders
- James Garner
